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ABSTRACT
The dry root of Aconiti kusnezoffii, also named Cao Wu, is widely used as folk medicine in China to treat rheumatic pain, paralysis
due to stroke, carbuncle, and furuncle. In the present study we investigated the molecular mechanisms of its analgesic and anti-inflammatory activities. Using the acetic acid-induced writhing and formalin test models in mice, our results clearly showed that the constituents of processed Radix Aconiti Kusnezoffii can reduce both peripherally and centrally induced pain in a dose-dependent manner. Mice
treated with processed Radix Aconiti Kusnezoffii has significantly increased levels of glutathione peroxidase, glutathione reductase,
and superoxide dismutase activities in the liver compared to untreated controls. Furthermore, treated mice exhibited lower levels of
malondialdehyde after carrageenan injection compared to untreated controls. In conclusion, our results demonstrate that the ingredients
in the processed Radix Aconiti Kusnezoffii can effectively reduce pain involving in the peripheral and central nervous systems and
exhibit anti-inflammatory activity. The pharmacological analgesic and anti-inflammatory properties of Radix Aconiti Kusnezoffii may
be attributed to the elevation of hepatic anti-oxidative enzymes to eradicate free radicals.
Key words: Antinociceptive activity, Anti-inflammatory activity, Radix Aconiti Kusnezoffii (Cao Wu).

INTRODUCTION
The Ranunculaceae family is relatively primitive in
evolution, and contains a great number of medicinal plants.
Members of the genus Aconitum are widely distributed across
North America and the northern part of Asia. This perennial
plant can grow up to 3 ft (1 m) with tuberous roots, palmately
lobed leaves, blue or white flowers with large hoodlike upper
sepals, and an aggregate of follicles(1). There are 167 species
of Aconitum found in mainland China, and 44 of them have
been used to treat rheumatic pain, paralysis due to stroke,
carbuncle, and furuncle(2). However, the narrow therapeutic
window of Aconitum limits its medical applications(3).
Several diterpenoid alkaloids have been isolated and identified from the roots of Aconitum, and the major constituents
have been reported to have analgesic, antipyretic, and local
anaesthetic properties(4).
Radix Aconiti Kusnezoffii, named Cao Wu in Chinese,
is the dry root of Aconiti kusnezoffii Reichb, which belongs
to the plant family of Ranunculaceae(5). The major components of Radix Aconiti Kusnezoffii are alkaloids, such
* Author for correspondence. Tel: +886-4-22030380;
Fax: +886-4-22083362; E-mail: yschang@mail.cmu.edu.tw

as aconitine, mesaconitine, jesaconitine, and hypaconitine, as well as non-alkaloid constituents such as sucrose,
daucosterin, meso-inositol, and higher fatty acids(6). The
crude Radix Aconiti Kusnezoffii was reported as highly toxic
in early Chinese medicinal literatures(7-8), and its misuse can
be fatal. However, with the traditional preparation method,
processed Radix Aconiti Kusnezoffii can be used clinically
with the significant reduction in toxicity.
Inflammation is a response to tissue damage that involves
enzyme activation, cytokine release, organ swelling, cell
migration, and tissue repair(9). The release of free radicals
from damaged tissues has been demonstrated to play a very
important role during inflammation, and can be identified
within the first six hours after λ-carrageenan administration,
along with elevated levels of prostaglandins and nitric-oxide.
Several studies also indicated that inflammation can stimulate malondialdehyde (MDA) production in response to cell
membrane damage arising from free radicals(10). Therefore,
in this study, we analyzed the active components and evaluated the antipyretic activity and anti-inflammatory effects
of concocted Actonitum using the acetic acid-induced body
twist test and formalin-induced pain assay. To further investigate the anti-inflammatory mechanism, we determined
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MDA levels in paw edema, as well as the concentrations
of lipid peroxide, superoxide dismutase (SOD), glutathione
peroxidase (GPx), and glutathione reductase (GRx) in the
liver. We also evaluated the anti-inflammatory effects of the
Radix Aconiti kusnezoffii in the carrageenan induced acute
and chronic inflammation models in rats.

MATERIALS AND METHODS

(n = 10) of either sex, selected by random sampling, were
employed in this study. The animals were fasted for 4 h with
free access to water only. Aqueous extracts of the tested
Aconitum plants and alkaloids were administered orally at
the desired doses and survival was observed over 3 days.
If mortality was observed in 2/3 or 3/3 animals, the dose
administered was considered toxic. However, if mortality
was observed in only 1/3 of animals, the same dose was
repeated to confirm the toxic effect again.

I. Collection of Plants

V. Carrageenan-induced Paw Edema

Radix Aconiti Kusnezoffii were collected from a pharmacy in Chengdu, the capital of Sichuan Province in China,
and identified by Prof. Y. C. Wu (China Medical University,
Taiwan). Voucher specimens of Radix Aconiti Kusnezoffii
have been deposited at the Herbarium of Graduate Institute
of Chinese Pharmaceutical Sciences, College of Pharmacy,
China Medical University, Taichung, Taiwan, under the
reference numbers of CMC7021 and CMC7022. Aconitine,
acetic acid, formalin, λ-carrageenan and indomethacin were
purchased from Sigma-Aldrich, Inc. (St. Louis, MO, USA).
The SOD, GPx, GR and MDA activity kits were purchased
from Randox Laboratory Ltd. Mesaconitine and hypaconitine
were purchased from Boppard (H. K. Co., Ltd., Hong Kong).
All other reagents were obtained from standard sources.

The carrageenan-induced paw edema test, an acute
inflammatory model first proposed by Winter et al.(13),
was used with modifications. Animals were fasted for
24 h before the experiment, with free access to water. A
0.05 mL of 1% (w/v) carrageenan solution in normal saline
was injected intradermally into the plantar side of the right
hindpaw of each mouse. Animals received an oral (p. o.)
dose of Aconitum extract or an intraperitoneal (i. p.) injection of indomethacin 1 h prior to carrageenan injection. Paw
volumes were measured immediately after carrageenan
injection using a plethysmometer (Model PP0, Diagnostic &
Research Instruments Co., Ltd., Taiwan) at 1 h intervals until
4 h after the injection of the carrageenan.
To induce inflammation, a suspension (50 µL) of
λ-carrageenan was injected subcutaneously into the right
hind limbs of one mice. After 2 h of induction, mice in
the test group were treated orally with different doses of
the crude extract, in a volume of 0.1 mL/10 g body weight.
Mice in the control group were given i. p. injections of indomethacin (10 mg/kg) after 1.5 h of induction. After 3 h of
induction, both groups were sacrificed using pentobarbital,
and the blood, hepatic lobar tissue, and foot tissue were
collected. One gram of liver tissue was homogenized with
1 mL normal saline using a homogenizer in an ice bath. The
homogenate was transferred to Eppendorf tubes and centrifuged at 12,000 rpm for 10 min at 4°C. The clear upper layer,
which was the liver extract, was then aliquotted into new
Eppendorf tubes and stored at -80°C for subsequent use.

II. Preparation of the Plant Extract
One kilogram of Radix Aconiti Kusnezoffii powdered
samples (100 mesh) were immersed in 5000 mL distilled
water for 30 min, and then boiled for 1 h. Filtration and
collection of the extracts were repeated three times. The
combined decoctions were evaporated to dryness. The
percentage of the lyophilized extract yield in processed
Radix Aconiti Kusnezoffii was 18.34% (w/w). The lyophilized extract was dissolved in saline solution prior to its use
in pharmacological tests.
III. Animals
Male BALB/c albino mice weighing 18 to 22 g were
obtained from the National Laboratory Animal Center
(Taipei, Taiwan). The animals were fed standard chow
(Purina Mills, Inc.), given water ad libitum, and maintained
under well-ventilated conditions with a 12h:12h light-dark
cycle. All animal procedures were performed according to
the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health, as well as the guidelines
of the Animal Welfare Act. All tests were conducted under
the guidelines of the International Association for the
Study of Pain(11).
IV. Acute Oral Toxicity Studies
Acute oral toxicity studies were performed according
to OECD-423 guidelines (acute toxic class method)(12). Mice

VI. Antioxidant Enzymes Activity Measurements
(I) The Superoxide Dismutase (SOD) Assay
The liver extract (15 μL) was placed in an Eppendorf
tube and mixed for 15 min with 90 μL ice-cold double
distilled water at 4°C. Then, 20 μL of the mixture was added
to 260 μL 0.1 M phosphate buffer containing 3-cyclohexylamino-1-propanesulfonic acid (CAPS 40 mM) and EDTA
(0.96 mM, pH 7.0). A 5 μL volume of the mixture was added
to 340 μL of mixed substrate (xanthine, 0.05 mM; I.N.T.,
0.025 mM) and xanthine oxidase to determine the colorimetric reaction. Light absorbance was recorded at 37°C and
505 nm on a Hitachi U 2000 Spectrophotometer. One unit
of SOD activity was defined as the rate of inhibiting the
spontaneous oxidation of I.N.T. within a certain time unit
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(U), and the SOD activity in the liver tissue is represented
as U/mg protein(14).
(II) Glutathione Reductase(GRx) Assay
This assay was based on the method by Guntherber
and Rost(15). Liver extract (100 μL) was added to 100 μL
cold ddH2O and kept at 2 to 8°C for 10 min, followed by
centrifugation at 12,000 rpm for 5 min. The supernatant
(25 μL) was collected and diluted with 475 μL normal
saline. Finally, 50 μL of the mixture was added to a cuvette,
followed by the sequential addition of equal amounts of GRx
buffer (250 mM, kupferrphosphate, 0.5 mM EDTA, pH 7.3),
substrate oxidized glutathione (GSSG) 2.2 mM and NADPH
(0.17 mM). Light absorbance was read at 340 nm, and GRx
activity was expressed as U/mg protein.
(III)Glutathione Peroxidase (GPx) Assay
This assay was based on the method by Paglia and
Valentine(16), who utilized the reaction of glutathione and
cumene hydroperoxide with GPx, and the following rapid
reduction of GSSG by NADPH and GRx. The coupled
reaction was accompanied by the oxidation of NADPH to
NADP+. GPx activity was defined by the decreased rate in
light absorbance. Twenty-five microliter of the extract was
diluted with 500 μL of diluting agent. Five hundred microliter of the clear supernatant was immediately mixed with
Reagent 1 (glutathione, 4 mM; GRx, 0.5 U/L; NADPH, 0.28
mM) and Reagent 2 (cumene hydroperoxide, 0.18 mM).
Light absorbance was read at 340 nm at 37°C and the rate of
absorbance change was calculated. GPx activity was shown
in U/mg protein.
(IV)MDA Assay
The quantitative assay for the lipid peroxide malondialdehyde (MDA) was performed by the method described
by Tatum, Changchit and Chow in 1990(17), based on the
fact that MDA and thiobarbituric acid (TBA) can form a red
adduct, TBARS, under acidic condition at high temperature.
One gram of foot tissue was homogenized with 2 mL normal
saline and centrifuged at 12,000 rpm for 5 min at 4°C. The
supernatant was combined with 45 μL BHT reagent and
300 μL TBA reagent in a mixer and heated in water bath
at 90°C for 45 min. After cooling to room temperature for
10 min, 495 μL of n-butanol was added and mixed for 1 min.
After centrifugation at 12,000 rpm for 15 min at 4°C, 100 μL
of the supernatant (pink color) was used to measure light
absorbance at 532 nm for four repeats on an ELISA reader.
VII. Detection of Aconitum Alkaloids
Aconitine, hypaconitine, and mesaconitine were
weighed accurately (1 mg) and dissolved in 10 mL absolute methanol to make stock solutions. The dried powder
of processed Radix Aconiti Kusnezoffii was weighed

accurately (1 g) and mixed with 30 mL abs. MeOH and
then extracted ultrasonically for 35 min. The extraction
process was repeated twice, and the extracts were combined
and evaporated to dryness under a stream of nitrogen gas.
The dried residues were dissolved in 10 mL abs. MeOH
and filtered through a membrane filter (0.45 μm) prior to
injection.
Analysis were carried out on an HPLC system consisting
of a Waters 2695 separation module and a Waters 2996 photodiode array detector (Waters, Milford, MA, USA) equipped
with an XBridge Shield RP-18 column (4.6 ID × 250 mm,
particle size 5 μm). The eluents were A (aqueous 0.03 M
ammonium hydrogen carbonate, adjusted to pH 9.5 with
concentrated ammonia) and B (100% acetonitrile). The flow
rate was maintained at 0.8 mL/min with an isocratic system
consisting of 85% solvent A and 15% solvent B. The detection wavelength was set at 235 nm. The column temperature
was 35°C, and the sample injection volume was 10 μL(18) .
VIII. Antinociceptive Activity
(I) Acetic Acid-induced Writhing Test
The acetic acid-induced writhing test was performed
using a modification of the method described by Koster et
al.(19). Mice were first pretreated with an oral (p. o.) doses
of either aqueous extracts or alkaloids, or with the standard
antinociceptive compound indomethacin (10 mg/kg i. p.).
Test compounds were administered 1 h before the i.p. injection of acetic acid (0.75%, v/v, 0.1 mL/10 g body weight) to
induce the typical stretching response. After induction, pairs
of mice were placed in separate boxes and the number of
writhes or stretches for each animal were counted for a period
of 5 min within a 15 min period of double-blind observation.
The antinociceptive effect was measured by calculating the
mean reduction in the number of abdominal constrictions
for mice treated with Radix Aconiti kusnezoffii extracts or
indomethacin, as compared with the vehicle-treated group.
The evaluation of antinociceptive activity was expressed
as inhibition or percent reduction in the number of total
abdominal writhes
(II) Formalin Test
The method used was similar to that described by
Hunskaar and Hole(20). To evoke a nociceptive response,
mice were injected under the dorsal surface skin of the
right hind paw with 20 μL of dilute formalin (1%) using
a 30 gauge needle. Each mouse was placed immediately
into a glass cylinder fitted with mirrors to enable a total
panoramic view of the animal’s behavior. The number of
paw shakes and the accumulated time spent in licking the
injected paw were taken as indicators of the nociceptive
response. Two periods of high licking and shaking activity
were considered: the first one was obtained immediately
after injection and lasted for 5 min; this is known as early
(neurogenic) phase. A second period was observed 20-30
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min after formalin injection and dominated the late (inflammatory) phase. Animals were administered with processed
Radix Aconiti Kusnezoffii extracts (p. o.) or indomethacin
(10 mg/kg, i. p.) 1 h before the injection of formalin. The
time spent in paw-licking behavior during each phase was
used to quantify the pain response.

Dunnett range post-hoc comparisons to determine the
source of significant differences where appropriate. Values
of p < 0.05 were considered statistically significant.

IX. Statistical Analysis

I. Quantitative Analysis

Statistical differences among groups were determined
using two-way repeated-measures ANOVA, followed by

HPLC chromatograms of standards and the sample
solution are shown in Figure 1. Linear regression analysis

RESULTS
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Figure 1. HPLC chromatograms of (A) aconitine, (B) mesaconitine, (C) hypaconitine and (D) Radix Aconiti Kusnezoffii extract.
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for each alkaloid was performed by the external standard
method. The calculated results are given in Table 1, where a
and b were the coefficients of the regression equation y = ax
+ b (x referred to the concentration of the alkaloid (μg/mL); y
denoted the peak area) and r represented the correlation coefficient of equation. All the alkaloids showed good linearity
(r = 0.999) in the concentration range. (Table 1) The average
recovery for the alkaloids was higher than 98% (Table 2). The
precision of the intra-day and inter-day data was indicated by
RSD which were less than 3.2% for each alkaloid at three
concentrations (Table 3). The order of concentration of three
aconitine-type alkaloids in Radix Aconiti Kusnezoffii was
mesaconitine (431.6 ± 3.2 μg/g) > aconitine (105.3 ± 1.3 μg/g)
> hypaconitine (67.2 ± 0.9 μg/g).

Additionally, mortality was not observed in mice receiving
the alkaloid constituents aconitine, mesaconitine, or
hypoaconitine at an oral dose of 0.5 mg/kg for 3 days.

II. Acute Oral Toxicity Test

IV. Acetic Acid-Induced Writhing Response

We found no instance of mortality in mice receiving
Radix Aconiti Kusnezoffii, even at the highest oral dose
(60 mg/kg) employed, and oral doses of 20, 40, and 60
mg/kg were selected for further pharmacological studies.

The effects of treatments on the writhing response
in mice are shown in Table 4. Indomethacin resulted in a
marked (83.2%) reduction in the number of writhes. Radix
Aconiti Kusnezoffii reduced the number of acetic acidinduced abdominal writhes in a dose-dependent manner
(r = 0.997). Radix Aconiti Kusnezoffii at the highest does
tested (60 mg/kg) produced a nearly 70% reduction in the
induced nociceptive response.
Table 4 also shows that aconitine and mesaconitine
(0.5 mg/kg, p.o.) effectively reduced the number of writhes
in mice by 75.3 ± 2.5 and 80.4 ± 3.2%, respectively. Hypoconitine (0.5 mg/kg, p.o.) produced only a modest (15.1 ±
2.1%) reduction in the number of writhes.

Table 1. Linear regression equation of the alkaloids
Compound

Concentration
rang (μg/mL)

Regression equation

r

Aconitine

0.310 - 40

y = 10067x -1084.71

0.9999

Mesaconitine

0.625 - 40

y = 15998x -126.15

0.9998

Hypaconitine

3.125 - 50

y = 13642x -1092.34

0.9999

III. Carrageenan-Induced Paw Edema
Subplantar injection of carrageenan in mice produced
a time-dependent increase in paw volume (Figure 2). The
increase was observed at 1 h and was maximal 4 h after
administration of carrageenan injection in the vehicle-treated
groups. Indomethacin markedly reduced the carrageenaninduced paw edema at all assessment time. Radix Aconiti
Kusnezoffii also reduced carrageenan-induced paw edema
in all phases of the experiments.

Values were obtained from 4 concentrations of each compound.

Vehicle
Indomethacin (10 mg/kg)
Radix Aconiti Kusnezoffii (20 mg/kg)
Radix Aconiti Kusnezoffii (40 mg/kg)
Radix Aconiti Kusnezoffii (60 mg/kg)

Table 2. Contents of Aconitum alkaloids in Radix Aconiti Kusnezoffii
Content (μg/g)

Recovery (%)

Aconitine

105.3 ± 1.3

98.47

Mesaconitine

431.6 ± 3.2

98.72

Hypaconitine

67.2 ± 0.9

98.15

Values (mean ± SEM) were obtained from 4 replicate.

Table 3. Precision of the intra-day and inter-day measurements
RSD (%)

Compound

Concentration
(μg/mL)

Intra-day

Inter-day

Aconitine

20.00

1.13

2.67

2.50

1.03

1.89

0.31

3.12

2.51

20.00

2.83

2.44

2.50

1.19

1.59

0.31

3.03

2.84

20.00

1.24

1.92

2.50

1.39

1.49

0.31

3.06

2.28

Mesaconitine

Hypaconitine

Values were obtained from 4 replicate of each group.
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Figure 2. Effects of the oral administration of aqueous extract of
Radix Aconiti Kusnezoffii on carrageenin-induced paw edema in
mice. Indomethacin (10 mg/kg) was administered intraperitoneally
to the separate group of mice. The vehicle (normal saline) used to
dissolve the tested medications was given at the same volume. Values
(mean ± SEM) were obtained from each group of 8 animals. ap < 0.05
and bp < 0.01 compared to the values of vehicle-treated group at the
indicated times, respectively.
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V. Formalin-Induced Paw-Licking in Mice
Radix Aconiti Kusnezoffii produced a dose-dependent
reduction in paw-licking time in both phases of the formalininduced paw-licking test (Table 5). In contrast, indomethacin
had no significant effect on paw-licking behavior in the early
phase of the nociceptive response, but markedly reduced
paw-licking time in the late phase of the response (Table 5).

(Table 6). Peritoneal injection of indomethacin and oral administration of Radix Aconiti Kusnezoffii (40 and 60 mg/kg)
reduced MDA levels in the hind paws of mice (Figure 3).

DISCUSSION
The genus Aconitum contains a toxic diester diterpenoid

VI. Antioxidant Enzymes Activity and MDA Levels

Table 4. Effects of Radix Aconiti Kusnezoffii and Aconitum alkaloids on acetic acid-induced writhing response in mice
Treatment
Vehicle
Indomethacin ( 10 mg/kg, i.p.)
Radix Aconiti Kusnezoffii (20 mg/kg, p.o.)

Number of Inhibition
writhes
(%)
(15 min)
－
30.4 ± 1.8

a

a

0.20

b

0.15
0.10
0.05
0.00

vehicle

indo

20

21.2 ± 2.0a 30.3 ± 2.7
14.3 ± 1.2

Radix Aconiti Kusnezoffii

9.6 ± 0.6

b

Aconitine (0.5 mg/kg, p.o.)

7.6 ± 0.9b 75.3 ± 2.5

Mesaconitine (0.5 mg/kg, p.o.)

5.9 ± 0.8b 80.4 ± 3.2

Hypaconitine (0.5 mg/kg, p.o.)

0.25

5.1 ± 1.0b 83.2 ± 2.4
a

Radix Aconiti Kusnezoffii (40 mg/kg, p.o.)

0.30

MDA concentration (nmol/mg protein)

Oral administration of the extract of Radix Aconiti
Kusnezoffii (20, 40, and 60 mg/kg) boosted the activity of
the anti-oxidative enzymes SOD, GR, and GRx in the liver

25.8 ± 1.2

40

60

Radix Aconiti Kuszezoffii (mg/kg)

52.9 ± 1.8

Carr.

69.4 ± 2.9

Figure 3. Effects of Radix Aconiti Kusnezoffii and indomethacin(
Indo) On carrageenan induced MDA concentrateion of the edema paw
at 3rd hour in mice. Indomethacin (10 mg/kg) was administered intraperitoneally to the separate group of mice. The vehicle (normal saline)
used to dissolve the tested medications was given at the same volume.
Values (mean ± SEM) were obtained from each group of 8 animals. ap
< 0.05 and bp < 0.01 compared to the values of vehicle-treated group at
the indicated times, respectively.

15.1 ± 2.1

Values (mean ± SEM) were obtained from each group of 8 animals.
a
p < 0.05 and bp < 0.01 compared to the values of vehicle-treated
group, respectively.

Table 5. Effects of Radix Aconiti Kusnezoffii on the early phase and late phase of formalin test in mice
First phase
Vehicle

Second phase

Licking time (sec)

Inhibition (%)

Licking time (sec)

Inhibition (%)

96.4 ± 7.9

－

164.6 ± 9.2

－

b

70.2 ± 3.2

Indomethacin ( 10 mg/kg, i. p.)

90.2 ± 8.4

6.4 ± 1.2

49.2 ± 5.6

Radix Aconiti Kusnezoffii ( 20 mg/kg, p.o.)

60.8 ± 3.5a

36.9 ± 2.6

53.6 ± 4.3b

67.7 ± 4.2

Radix Aconiti Kusnezoffii ( 40 mg/kg, p.o.)

b

53.1 ± 3.2

b

70.9 ± 2.9

b

78.4 ± 3.3

Radix Aconiti Kusnezoffii ( 60 mg/kg, p.o.)

45.2 ± 5.4

b

30.9 ± 2.8

47.7 ± 3.9

67.9 ± 4.1

35.4 ± 2.7

Values (mean ± S.E.M.) were obtained from each group of 8 animals. a P < 0.05 and bP < 0.01 compared to the values of vehicle-treated
group, respectively.

Table 6. Effects of the Radix Aconiti Kusnezoffii on the liver SOD, GPx, and GRx activities in mice
Groups

SOD
(U/mg protein)

GPx
(U/mg protein)

GRx
(U/mg protein)

Carr

39.0 ± 0.5

0.1866 ± 0.0006

0.0648 ± 0.0002

Carr + 20 mg/kg Radix Aconiti Kusnezoffii, p. o.

58.4 ± 0.2 a

0.3147 ± 0.0002 a

0.1087 ± 0.0001 a

Carr + 40 mg/kg Radix Aconiti Kusnezoffii, p. o.

60.5 ± 0.5 a

0.3542 ± 0.0003 a

0.1178 ± 0.0002 a

Carr + 60 mg/kg Radix Aconiti Kusnezoffii, p. o.
82.0 ± 0.5 b
0.3753 ± 0.0004 b
a
b
All values represents as mean ± SEM (n = 10). p < 0.05 and p < 0.01 compared to the carrageenan (Carr) group.

0.1191 ± 0.0001 b
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alkaloids, because it has beneficial pharmacological properties if used at proper dosage and, therefore, is an important
ingredient in many traditional herbal medicines. Radix
Aconiti Kusnezoffii also contains diester diterpenoid alkaloids, which can be destroyed by heat during concoction.
Processed Radix Aconiti Kusnezoffii thus has reduced
toxicity and can be used clinically. Therefore, processed
Radix Aconiti Kusnezoffii was used in this study for evaluation of its antinociceptive and anti-inflammatory activities.
Experimental animal models for the study of pain rely
on four damaging stimuli: mechanical, thermal, electrical,
and chemical stimulation(21). We evaluated the analgesic
properties of agents using the acetic acid-induced writhing
test and the formalin test in mice. Both involve chemicallyinduced pain. The writhing response can be suppressed by
neural analgesic substances, such as opium and endopeptides, and peripheral anti-pyretic analgesic substances such
as steroidal and non-steroidal anti-inflammatory drugs
(NSAIDS). Acetic acid-induced pain is sensitive to NSAIDS,
anesthetic agents, and other central nervous system-active
medicines so that the acetic acid-induced writhing model is
widely used to evaluate analgesic effects of compounds(22).
The model is based on pain emanating from internal organs,
which is mediated through prostaglandins generated from
arachidonic by the enzyme cyclooxygenase. Increased
prostaglandin levels, particularly PGE2α, can be detected
quantitatively in peritoneal fluid after acetic acid injection
using radioimmunoassay. Thus, prostaglandin production
plays an important role in the pain response. This study
showed that Radix Aconiti Kusnezoffii is able to produce a
dose-dependent reduction in acetic acid-induced writhing,
to a degree comparable to indomethacin. In addition, the
analgesic effect might be associated with the inhibition of
arachidonic acid metabolism.
The aconitine-alkaloids aconitine, mesaconitine and
hypaconitine were used as standards in analyzing the components of Radix Aconiti Kusnezoffii. Among these alkaloids,
mesaconitine was found to be the most abundant constituent
of Radix Aconiti Kusnezoffii, followed by aconitine and
then hypaconitine. In the acetic acid-induced writhing test,
mesaconitine and aconitine exhibited marked analgesic
effects, producing significant reductions in body writhing.
In the formalin test, dilute formalin is injected subcutaneously into the hind paw of rats, evoking a sustained
damaging stimulation that leads to an obvious, long-lasting,
and spontaneous pain response characterized by leg flinches,
leg licking, and trembling(23). This model can mimic some
elements of human pain syndromes in response to injury
and is quite reproducible(23). The paw-licking response to
formalin is biphasic. The first or early phase, representing
acute neurogenic pain, occurs from 0 to 5 min after formalin
injection. Pain in this phase is transmitted mainly through
the release of neurotransmitters such as substance P and
bradykinin, which directly stimulate nociceptors. The
transmission of pain signals in this phase is via Aδ and C
nerve fibers. This phase represents a central nervous systeminduced pain response. After a latent period, a second, late

phase representing inflammatory pain becomes evident
over the period of 15 to 30 min after formalin injection. Late
phase pain is associated with chemical mediators such as
histamine, serotonin, PGE2, and kinins, which are secreted
from cells damaged as a result of the formalin-induced
inflammatory reaction. This phase represents a peripherally
induced pain response(24). Our results showed that Radix
Aconiti kusnezoffii had an analgesic effect to reduce both
central and peripheral nervous system-induced pain.
A common animal model for the investigation of antiinflammatory drugs is λ-carrageenan injection into the foot
of a mouse(25). This triggers increased permeability of local
blood vessels, resulting in foot swelling. This method is
often employed to evaluate the efficacy of anti-inflammatory agents and the anti-edema effects of natural products.
The response to the injection of λ-carrageenan-induced paw
edema is biphasic, and the injected λ-carrageenan releases
various substances with time to induce inflammation. In
phase I, within 1 to 2 h of λ-carrageenan injection, histamine, serotonin and other mediators are released. During
phase II, i. e., within 3 to 5 h of injection, prostaglandin
is released. Between the two phases, the substances like
kinin are released(26). There are also studies showing that
λ-carrageenan-induced inflammation is associated with
free radicals. Radix Aconiti Kusnezoffii was shown to exert
anti-inflammatory activity in both phases of the response,
especially at the dose of 40 mg/kg, which presented the best
efficacy. It can therefore be deduced that the anti-inflammatory action of Radix Aconiti Kusnezoffii can be attributed
to inhibiting the release of the early phase mediators, such
as histamine and serotonin, and the late-phase substance
prostaglandin.
Reactive oxygen species (ROS) have been thought to
play an important role in the onset and progression of many
diseases, such as arteriosclerosis, inflammation, cancer, and
cardiovascular diseases(27). In the inflammatory process,
ROS not only causes tissue damage, but also activates arachidonic acid metabolism, cytokines, and heat-shock proteins,
and induces apoptosis(27). Therefore, the reduction of ROS
levels during inflammation can result in an effective antiinflammatory effect. Many antioxidative enzymes exist in
the liver to antagonize free radicals. SOD is an antioxidative
enzyme that is able to remove free radical ions and proteins.
It is critical in protecting against the toxicity of oxygen
radicals, delaying aging, and preventing tumor development
and inflammation. Its activity indirectly reflects the ability
of the body to clear oxidative free radicals(27). MDA is the
decomposed product of lipid peroxide, generated from the
free radical-damaged unsaturated fatty acids, and is one of
the most important products in lipid peroxidative reaction.
MDA levels in tissues can be directly linked to the rate and
degree of lipid peroxidation(28). GPx exist in all kinds of
human tissues and cells. It can induce GSH to reduce intracellular superoxide, leading to the elimination of peroxides
from the body, thereby preventing lipid oxidation(27). GSH
can be further reduced to GSSH by glutathione reductase(27).
Our results showed that the anti-inflammatory mechanism
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of Radix Aconiti kusnezoffii may be attributed to the elevation of anti-oxidative enzymes in the liver to eradicate free
radicals. Additionally, there is also a suppression of MAD
levels in the inflammatory footpad, reducing lipid oxidation
and thus contributing to the anti-inflammatory effect.
In many traditional medicines in China and Japan, the
genus Aconitum is widely used for its analgesic, anti-inflammation, and blood sugar-lowering properties and for treating
diseases of the nervous system. The results of this investigation indicate that Radix Aconiti kusnezoffii exhibits an
antinociceptive activity at both central and peripheral levels
and an expressive anti-inflammatory effect. Besides, care
has to be taken while using Aconitum in the clinical administration due to it’s lower therapeutic range. This represents
an example of the use of modern scientific methodology to
verify traditional Chinese medicine theory, and studies like
this should facilitate the incorporation of Chinese herbal
medicines into clinical applications.
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